XML 65 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

Loss Per Share | 12 Months Ended
--- | ---
Feb. 28, 2025
Earnings Per Share [Abstract] |
Loss Per Share | NOTE 19 – Loss Per Share The following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of dilutive potential common stock for the years ended February 28, 2025 and February 29, 2024: Schedule of Earnings Per Share, Basic and Diluted
|  | 2025 |  |  | 2024 |
|  | Year Ended February |
|  | 2025 |  |  | 2024 |
Loss from continuing operations |  | $ | (10,128,428 | ) |  | $ | (6,656,837 | )
Preferred dividends |  |  | (78,600 | ) |  |  | (7,125 | )
Loss from continuing operations applicable to common stockholders |  |  | (10,207,028 | ) |  |  | (6,663,962 | )
Gain (loss) from discontinued operations applicable to common stockholders |  |  | 8,344 |  |  |  | (675,314 | )
Net loss applicable to common stockholders |  | $ | (10,198,684 | ) |  | $ | (7,339,276 | )
Weighted average number of common shares Outstanding used in loss per share during the Period (denominator) |  |  | 4,566,787 |  |  |  | 228,274 |
On June 10, 2024, the Company determined that three of the four business milestones per the Exchange Agreement had been achieved. As a result, 4,393,993 of the total Contingent Shares of 5,843,993 became eligible for issuance. Pursuant to ASC 260, as there are no circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings per share. The following table shows the business milestones and the issuable Contingent Shares: Schedule of Business Milestones and Issuable Contingent Shares
Business Milestones |  | Contingent Shares |
Achieved |  |  |  |
Launch of leisure travel booking platform |  |  | 1,450,000 |
Launch of group travel booking platform |  |  | 1,450,000 |
Launch of PayDlay technology |  |  | 1,493,993 |
Total contingent shares issuable on June 10, 2024 |  |  | 4,393,993 |
Not Achieved |  |  |  |
Launch of travel agent platform |  |  | 1,450,000 |
Total contingent shares potentially issuable in future periods |  |  | 1,450,000 |
Total contingent shares |  |  | 5,843,993 |
The following table shows the reconciliation of the weighted average common shares outstanding for the twelve months ended February 28, 2025 to the weighted average common shares used in the computation of basic earnings per share: Schedule of Weighted Average Common Shares
|  | February 28, 2025 |
1,656,738 common shares outstanding |  |  | 1,400,705 |
4,393,993 issuable contingent shares |  |  | 3,166,083 |
Weighted average common shares outstanding |  |  | 4,566,787 |
The issuable Contingent Shares are of the Company’s sole class of common stock, and as such have the same rights and privileges as existing common stock. Dilutive loss per share was not presented as the Company’s outstanding common and preferred warrants, stock options and preferred stock common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 28, 2025, the Company had outstanding warrants to purchase 3,105,885 shares of common stock; stock options exercisable for 76,342 shares of common stock; 316 shares of Series E Preferred, which could be converted into 3,362 shares of common stock; 33,000 shares of Series H Preferred, convertible into 33,000 shares of common stock; 500,442 shares of Series I Preferred, convertible into 500,442 shares of common stock; 297,788 shares of Series J Preferred, convertible into 297,788 shares of common stock; 60,595 shares of Series K Stock, convertible into 60,595 shares of common stock; 1,076,156 shares of Series L Preferred, convertible into 1,076,156 shares of common stock; 133,278 shares of Series M Preferred, convertible into 133,278 shares of common stock; 500,000 shares of Series N Preferred, convertible into 500,000 shares of common stock; 161,291 shares of Series O Preferred, convertible into 161,291 shares of common stock; and 343,750 shares of Series O Stock, convertible into 343,750 shares of common stock, resulting in a potential total additional 3,109,663 shares of common stock outstanding in the future. At February 29, 2024, the Company had 1,047,300 outstanding potentially dilutive securities.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration